Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03101618
Other study ID # GBIRB2016-155
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 24, 2016
Est. completion date November 27, 2016

Study information

Verified date February 2021
Source Gachon University Gil Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators surveyed the prevalence of animal allergy and sensitization to animal allergen among participants in international symposium of Korean association for laboratory science (laboratory animal researchers) and companion animal exhibition (pet owner and pet-related industry workers).


Description:

The investigators enrolled participants in international symposium of Korean association for laboratory science (laboratory animal researchers) and pet animal exhibition (pet owner and pet-related industry workers) after informed consents. Subjects were asked to response to questionnaires regarding their age, gender, comorbid allergic disease, family history of allergy, pet or laboratory animal, exposure time, allergic symptoms during exposure to animals. Subjects underwent skin prick test with animal allergens and other inhalant allergens.


Recruitment information / eligibility

Status Completed
Enrollment 643
Est. completion date November 27, 2016
Est. primary completion date November 27, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Participants in international symposium of Korean association for laboratory science and companion animal exhibition from whom informed consents were obtained. Exclusion Criteria: - Subjects who reject enrollment into this study.

Study Design


Intervention

Other:
Animal allergy
Allergic symptom occurs during exposure to laboratory or pet animal
Non-animal allergy
Allergic symptom does not occur during exposure to laboratory or pet animal

Locations

Country Name City State
Korea, Republic of Gachon University Gil Medical Center Incheon

Sponsors (1)

Lead Sponsor Collaborator
Gachon University Gil Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (3)

Krakowiak A, Wiszniewska M, Krawczyk P, Szulc B, Wittczak T, Walusiak J, Palczynski C. Risk factors associated with airway allergic diseases from exposure to laboratory animal allergens among veterinarians. Int Arch Occup Environ Health. 2007 May;80(6):46 — View Citation

Moghtaderi M, Farjadian S, Abbaszadeh Hasiri M. Animal allergen sensitization in veterinarians and laboratory animal workers. Occup Med (Lond). 2014 Oct;64(7):516-20. doi: 10.1093/occmed/kqu097. Epub 2014 Aug 7. — View Citation

Park YB, Mo EK, Lee JY, Kim JH, Kim CH, Hyun IG, Choi JH. Association between pet ownership and the sensitization to pet allergens in adults with various allergic diseases. Allergy Asthma Immunol Res. 2013 Sep;5(5):295-300. doi: 10.4168/aair.2013.5.5.295. Epub 2013 Jun 25. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Skin reactivity to animal allergens Positivity to animal allergens in skin prick test The day of survey
Secondary Skin reactivity to other inhalant allergens Positivity to other inhalant allergens in skin prick test The day of survey
Secondary The prevalance of cormobid allergy The prevalance of allergic rhinitis, allergic conjunctivitis, asthma, urticaria, atopic dermatitis, contact dermatitis, food allergy, drug allergy The day of survey
Secondary Duration of animal exposure Duration of laboratory or pet animal exposure (months) The day of survey
Secondary Animal contact time Animal contact time including direct contact and spatial sharing (min/day) The day of survey
Secondary Residence of animal Residence of animal (cage, bedroom, not bedroom but at home, outside) The day of survey
Secondary Site of animal defecation Site of animal defecation (outside, predetermined place at home, anywhere at home) The day of survey
Secondary Laboratory or pet animal Laboratory or pet animal which subject contacts The day of survey
Secondary Severity of allergic symptom Severity of allergic symptom (using visual analog scale) during exposure to animal The day of survey
Secondary Duration of allergic symptom Duration of allergic symptom during exposure to animal (min) The day of survey
Secondary Frequency of house cleaning, bed cleansing, animal haircut, and animal hair removal from their garmet Frequency of house cleaning, bed cleansing, animal haircut, and animal hair removal from their garmet in pet owners and pet-related industry workers The day of survey
Secondary Use of medical service Use of medical service including prescription and immunotherapy for animal allergy The day of survey
Secondary Perception of animal allergy, its avoidance and immunotherapy Agreement score (visual analog scale) to "Allergic symptom occurs during exposure to animal", "Avoidance can reduce or prevent from allergic symptom", "Immunotherapy can mitigate allergic symptom during exposure to animal" The day of survey
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device